LifeStance Health Group, Inc. Quarterly Operating Income (Loss) in USD from Q1 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
LifeStance Health Group, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2020 to Q2 2024.
  • LifeStance Health Group, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$15.9M, a 67.1% increase year-over-year.
  • LifeStance Health Group, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$139M, a 16.7% increase year-over-year.
  • LifeStance Health Group, Inc. annual Operating Income (Loss) for 2023 was -$189M, a 10% increase from 2022.
  • LifeStance Health Group, Inc. annual Operating Income (Loss) for 2022 was -$210M, a 26.6% increase from 2021.
  • LifeStance Health Group, Inc. annual Operating Income (Loss) for 2021 was -$286M.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$139M -$15.9M +$32.5M +67.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$172M -$16.8M +$17.3M +50.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$189M -$32.3M +$13.7M +29.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 -$203M -$74.4M -$35.5M -91.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 -$167M -$48.4M +$12.1M +19.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$179M -$34.1M +$30.8M +47.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$210M -$46M +$67.7M +59.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 -$278M -$38.8M +$85.8M +68.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$364M -$60.5M -$13.4M -28.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$350M -$64.9M -$64M -7261% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 -$286M -$114M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 -$125M -$127M -4733% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$47M -$47.1M -45336% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 -$881K -$3.94M -129% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q3 2020 $2.69M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $104K Apr 13, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $3.06M Apr 1, 2020 May 14, 2020 10-Q 2021-08-12
Q1 2020 $8.7M Jan 1, 2020 May 14, 2020 10-K 2023-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.